The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis Dahkki Singh, S, Boyd, S, Schilling, WHK, Watson, JA, Mukaka, M, White, NJ

The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions Dahkki Schilling, WHK, Callery, JJ, Chandna, A, Hamers, RL, Watson, J, White, NJ

Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled,... Dahkki Wongnak, P, Schilling, WHK, Jittamala, P, Boyd, S, Luvira, V, Siripoon, T, Ngamprasertchai, T, Batty, EM, Singh, S, Kouhathong, J, Pagornrat, W, Khanthagan, P, Hanboonkunupakarn, B, Poovorawan, K, Mayxay, M, Chotivanich, K, Imwong, M, Pukrittayakamee, S, Ashley, EA, Dondorp, AM, Day, NPJ, Teixeira, MM, Piyaphanee, W, Phumratanaprapin, W, White, NJ, Watson, JA

Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV) Dahkki Schilling, WHK, Callery, JJ, Taylor, W, Mukaka, M, Ekkapongpisit, M, Watson, JA, Chandna, A, Panapipat, S, Tubprasert, J, Yuentrakul, P, Waithira, N, Cope, T, Dhorda, M, Cruz, C, von Seidlein, L, Milton, J, LLewelyn, M, Adler, A, Chotivanich, K, Cheah, PY, Ashley, EA, Mayxay, M, Dondorp, AM, Phumratanaprapin, W, Day, NPJ, White, N

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial Dahkki Luvira, V, Schilling, WHK, Jittamala, P, Watson, JA, Boyd, S, Siripoon, T, Ngamprasertchai, T, Almeida, PJ, Ekkapongpisit, M, Cruz, C, Callery, JJ, Singh, S, Tuntipaiboontana, R, Kruabkontho, V, Ngernseng, T, Tubprasert, J, Abdad, MY, Keayarsa, S, Madmanee, W, Aguiar, RS, Santos, FM, Hanboonkunupakarn, P, Hanboonkunupakarn, B, Poovorawan, K, Imwong, M, Taylor, WRJ, Chotivanich, V, Chotivanich, K, Pukrittayakamee, S, Dondorp, AM, Day, NPJ, Teixeira, MM, Piyaphanee, W, Phumratanaprapin, W, White, NJ

Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV) Dahkki Schilling, WHK, Jittamala, P, Watson, JA, Ekkapongpisit, M, Siripoon, T, Ngamprasertchai, T, Luvira, V, Pongwilai, S, Cruz, CV, Callery, JJ, Boyd, S, Kruabkontho, V, Ngernseng, T, Tubprasert, J, Abdad, MY, Piaraksa, N, Suwannasin, K, Hanboonkunupakarn, P, Hanboonkunupakarn, B, Sookprome, S, Poovorawan, K, Thaipadungpanit, J, Blacksell, S, Imwong, M, Tarning, J, Taylor, WRJ, Chotivanich, V, Sangketchon, C, Ruksakul, W, Chotivanich, K, Teixeira, MM, Pukrittayakamee, S, Dondorp, AM, Day, NPJ, Piyaphanee, W, Phumratanaprapin, W, White, NJ

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adap... Dahkki Schilling, WHK, Jittamala, P, Watson, JA, Boyd, S, Luvira, V, Siripoon, T, Ngamprasertchai, T, Batty, EM, Cruz, C, Callery, JJ, Singh, S, Saroj, M, Kruabkontho, V, Ngernseng, T, Tanglakmankhong, N, Tubprasert, J, Abdad, MY, Madmanee, W, Kouhathong, J, Suwannasin, K, Pagornrat, W, Piaraksa, N, Hanboonkunupakarn, P, Hanboonkunupakarn, B, Poovorawan, K, Potaporn, M, Srisubat, A, Loharjun, B, Taylor, WRJ, Chotivanich, V, Chotivanich, K, Imwong, M, Pukrittayakamee, S, Dondorp, AM, Day, NPJ, Teixeira, MM, Piyaphanee, W, Phumratanaprapin, W, White, NJ

Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project Dahkki Chandna, A, Chew, R, Shwe Nwe Htun, N, Peto, T, Zhang, M, Liverani, M, Brummaier, T, Phommasone, K, Perrone, C, Phyo, AP, Ibna Zaman, S, Sandar Zaw, A, Batty, E, Waithira, N, Abdad, MY, Blacksell, S, Bodhidatta, L, Callery, J, Fagnark, W, Huangsuranun, W, Islam, S, Lertcharoenchoke, S, Lohavittayavikant, S, Mukaka, M, Pongvongsa, T, Ponsap, P, Richard-Greenblatt, M, Schilling, WHK, Thaipadungpanit, J, Tripura, R, Dondorp, A, Mayxay, M, White, N, Nosten, F, Smithuis, F, Ashley, E, Maude, R, Day, NPJ, Lubell, Y, Et al

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial Dahkki Schilling, WHK, Mukaka, M, Callery, JJ, Llewelyn, MJ, Cruz, CV, Dhorda, M, Ngernseng, T, Waithira, N, Ekkapongpisit, M, Watson, JA, Chandna, A, Nelwan, EJ, Hamers, RL, Etyang, A, Beg, MA, Sow, S, Yavo, W, Allabi, AC, Basnyat, B, Sharma, SK, Amofa-Sekyi, M, Yonga, P, Adler, A, Yuentrakul, P, Abdad, MY, Blacksell, SD, Tarning, J, Rahardjani, M, Rimainar, A, Akech, S, Hamaluba, M, Shrestha, S, Rijal, S, Woodrow, CJ, Cheah, PY, Taylor, WRJ, Batty, EM, von Seidlein, L, Dondorp, A, Day, NPJ, White, NJ

Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV) Dahkki Jittamala, P, Schilling, WHK, Watson, JA, Luvira, V, Siripoon, T, Ngamprasertchai, T, Almeida, PJ, Ekkapongpisit, M, Cruz, C, Callery, JJ, Boyd, S, Anunsittichai, O, Hongsuwan, M, Singhaboot, Y, Pagornrat, W, Tuntipaiboontana, R, Kruabkontho, V, Ngernseng, T, Tubprasert, J, Abdad, MY, Keayarsa, S, Madmanee, W, Aguiar, RS, Santos, FM, Batty, EM, Hanboonkunupakarn, P, Hanboonkunupakarn, B, Sookprome, S, Poovorawan, K, Imwong, M, Taylor, WRJ, Chotivanich, V, Sangketchon, C, Ruksakul, W, Chotivanich, K, Pukrittayakamee, S, Dondorp, AM, Day, NPJ, Teixeira, MM, Piyaphanee, W, Phumratanaprapin, W, White, NJ